Brief: Xspray Pharma Q3 Loss Before Tax At SEK 10.6 Mln
Nov 14 (Reuters) - XSpray Pharma AB (publ) XSPRAY.ST :
* XSPRAY PHARMA PUBLISHES INTERIM REPORT Q3, JANUARY -
SEPTEMBER
2019
* JUL-SEPT EARNINGS BEFORE TAX AMOUNTED TO SEK -10,583
THOUSAND
Source text for Eikon: ID:nWkr80Q3cc
Further company coverage: XSPRAY.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 772 0920;))
Recent news on Xspray Pharma publ AB
See all newsBrief: Xspray Pharma Gets CRL From FDA
Sweden's Xspray Q1 loss narrows, upbeat on Dasynoc prospects
Brief: Xspray Pharma Q1 Pretax Loss SEK 35.4 Mln
Brief: Xspray Pharma To Receive About SEK 113 Million From Rights, Over-Allotment Issues
Brief: FDA Accepts Trade Name Nilopki For Xspray's Drug Candidate XS003